Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors

MLA

Lynn W.W. Tsang, et al. “Dexfenfluramine in Obese Chinese NIDDM Patients. A Placebo-Controlled Investigation of the Effects on Body Weight, Glycemic Control, and Cardiovascular Risk Factors.” Diabetes Care, vol. 20, no. 7, July 1997. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6516759f654b05cd505aa1de782e9437&authtype=sso&custid=ns315887.

APA

Lynn W.W. Tsang, Gary Tc Ko, Vincent T.F. Yeung, Juliana C.N. Chan, Chun-Chung Chow, & Clive S. Cockram. (1997). Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors. Diabetes Care, 20(7).

Chicago

Lynn W.W. Tsang, Gary Tc Ko, Vincent T.F. Yeung, Juliana C.N. Chan, Chun-Chung Chow, and Clive S. Cockram. 1997. “Dexfenfluramine in Obese Chinese NIDDM Patients. A Placebo-Controlled Investigation of the Effects on Body Weight, Glycemic Control, and Cardiovascular Risk Factors.” Diabetes Care 20 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6516759f654b05cd505aa1de782e9437&authtype=sso&custid=ns315887.